BioSpace News Archive

InMode Ltd. (Nasdaq:INMD) (“InMode”) announced today the closing of its initial public offering of 5,000,000 ordinary shares at an initial public offering price of $14.00 per ordinary share.

Signant Health ( HYPERLINK “http://www.signanthealth.com” signanthealth.com), a leading provider of technology for clinical research, today launches the Signant Health Partner Program, a significant investment the company is making to enable clinical research organizations (CROs) to better serve sponsors in the areas of Patient Data, Patient Experience, Clinical Supplies, and Endpoint Quality Solutions

March of Dimes released the following statement from Stacey D. Stewart, President and CEO, in response to the Administration’s action today finalizing the rule on the circumstances under which immigrants could be considered a “public charge,” thereby endangering their immigration status.

Harvard, Merck to collaborate on research led by Harvard immunologist Arlene Sharpe, seeking to identify new pathways for the treatment of cancer

AVROBIO, Inc. announced that the Company granted non-statutory stock options to new employees as inducement awards outside of the Company’s 2018 Stock Option and Incentive Plan in accordance with NASDAQ Listing Rule 5635.

Prometic Life Sciences Inc. announced financial results for its fiscal 2019 second quarter ended June 30th 2019.

Propanc Discusses Next Steps for Promising Research Collaboration with University of Jaén and Granada to Further Optimize Quality, Safety and Performance of PRP